Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
Delhi will continue plasma trials: Kejriwal Last Updated : 01 May 2020 01:37:51 PM IST Delhi Chief Minister Arvind Kejriwal Delhi Chief Minister Arvind Kejriwal on Friday said Delhi will continue the trail of Plasma therapy as it has approval from the Centre.
Delhi Chief Minister Arvind Kejriwal on Friday said Delhi will continue the trail of Plasma therapy as it has approval from the Centre."The Centre has only said that Plasma is on trial and it is not an official treatment. Delhi will continue the plasma trial as we have approval from the Centre," Kejriwal said while speaking to the media.He also said that he is happy that most of those who recovered in Delhi are ready to donate the plasma.On the students stuck in Kota in Rajasthan, Kejriwal also said that 40 buses from Delhi will go to Kota to bring back the students.
IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186